baber/WOPTO huggingface dataset:
Patent EP-1643895-A2 (EP)
Title: Dispositif inserable et systeme pour procede peu effractif
Inventor: FOWLER DENNIS L
IPC: A61B1/04
Filed: 2004-07-14
Abstract: L'invention concerne un système et un dispositif multifonctionnel à un seul élément ou à éléments multiples. Le dispositif peut être inséré et placé temporairement ou implanté dans une structure comportant une lumière ou un espace creux, telle que la cavité abdominale d'un sujet, pour permettre d'accéder à un site voulu, et s'utilise dans le cadre de procédés chirurgicaux peu effractifs. Le dispositif insérable peut être conçu de sorte que les éléments fonctionnels présentent divers degrés de liberté de mouvement par rapport à l'orientation de ceux-ci, pour permettre d'accéder au site à partir de multiples orientations/perspectives différentes requises par le procédé, p. ex. pour fournir de multiples vues sélectionnables du site et présenter une vision stéréoscopique du site voulu.
Patent EP-1625497-A2 (EP)
Title: Apparatus and methods for restoring synchronization to object-oriented software applications in managed runtime enviroments
Inventor: WU GANSHA
IPC: G06F9/45
Filed: 2004-03-19
Abstract: An example apparatus and method described herein involves determining if a class object has been dynamically loaded, performing an escape analysis on the program code and determining if assumptions made during an initial escape analysis are valid. Additionally, the example apparatus and method restore synchronization to at least a portion of the program code affected by loading of the class object if the assumptions made during the initial escape analysis are no longer valid.
Patent EP-1675594-A2 (EP)
Title: Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
Inventor: ANSORGE SIEGFRIED
IPC: C07D205/08
Filed: 2004-10-15
Abstract: The invention relates to medicinally used substances which specifically inhibit peptidases splitting Gly-Pro-p-nitroanilide. The invention further relates to the use of at least one such substance or at least one pharmaceutical or cosmetic composition containing at least one such substance for preventing and treating diseases, particularly diseases with an overshooting immune response (autoimmune diseases, allergies, and transplant rejections), other chronic inflammatory diseases, neuronal diseases, brain damages, skin diseases (acne and psoriasis, among others), tumor diseases, and special viral infections (including SARS).
Patent EP-1805089-A2 (EP)
Inventor: MASS NISSIM
IPC: A01F15/07
Filed: 2004-10-22
Abstract: L'invention porte sur un matériau de filet composite pour emballer des balles au moyen d'une presse de mise en balles. Ce matériau de filet composite comprend un composant de filet et un composant fait de matériau aéré. Ce composant fait de matériau aéré est en partie fixé au matériau de filet. Dans certains modes de réalisation, le matériau de filet est seulement fixé le long du bord d'attaque de chaque panneau de matériau aéré. Cette technique d'attache permet de ne pas transférer les propriétés d'étirement du filet au matériau aéré. Par conséquent, chaque composant du filet conserve ses propres propriétés. Chaque balle est d'abord emballée au moyen d'un emballage du matériau de filet, suivi d'un emballage de matériau aéré et d'un filet partiellement fixé qui présente une continuité depuis la première section. Par la suite, une ou plusieurs couches supplémentaires peuvent être appliquées le cas échéant.
Patent EP-1678195-A2 (EP)
Inventor: MESSMER BRADLEY T
IPC: A61K38/00
Filed: 2004-10-08
Abstract: La présente invention concerne des préparations isolées et purifiées d'une combinaison de chaînes d'anticorps à chaîne légère et de chaînes d'anticorps à chaîne lourde, les gènes d'anticorps de chaîne légère et de chaîne lourde étant les mêmes entre plus d'un patient atteint de leucémie lymphocytaire chronique de cellules bêta (B-CLL). Cette invention concerne aussi des vecteurs comprenant ces gènes et des cellules comprenant ces vecteurs, tels que sont des anticorps isolés et purifiés codés par ces gènes d'anticorps. Cette invention concerne aussi des anticorps anti-idiotype, des peptides et des aptamères qui se lient aux régions de liaison à l'antigène d'un anticorps codé par les gènes d'anticorps, tels que des molécules multimères comprenant des sites de liaison multiples qui se lient à des régions de liaison à l'antigène d'un anticorps codé par ces gènes d'anticorps. Cette invention concerne aussi des techniques permettant de déterminer si un patient atteint de leucémie lymphocytaire chronique de cellule bêta (B-CLL) présente une forme de B-CLL qui est susceptible de recevoir un traitement destiné à éliminer des cellules B-CLL porteuses de récepteur de cellule bêta spécifique d'idiotype, tels que les techniques qui suivent la progression du traitement de B-CLL chez ce patient. Par ailleurs, cette invention concerne des techniques de traitement d'un patient atteint de B-CLL, tels que des techniques d'identification d'agents thérapeutiques pour la B-CLL.
Patent EP-1678837-A2 (EP)
Inventor: MILLER MARK J
IPC: H04L27/12
Filed: 2004-10-28
Abstract: Spread spectrum GMSK signals are presented. Transmission may involve obtaining a sequence of data symbols(dn), obtaining a spread spectrum code (bk) comprising a sequence of spread spectrum chips, generating a sequence of pre-modulation chips (ak) by combining the sequence of data symbols with the spread spectrum chips, wherein for each data symbol, at least one of the pre-modulation chips is generated by taking into account at least the data symbol and at least one of the spread spectrum chips, performing Gaussian Minimum Shift Keying (GMSK) modulation using the sequence of pre-modulation chips to produce a spread spectrum GMSK signal, and transmitting the spread spectrum GMSK signal.
Patent EP-1694127-A2 (EP)
Inventor: HUNGENBERG HEIKE
IPC: A01N47/34
Filed: 2004-12-01
Abstract: The invention relates to insecticide mixtures that contain triflumuron and at least one additional known active substance from the group of chloronicotinyls, and to the use of said mixtures in pest control.
Patent EP-1694216-A2 (EP)
Inventor: CICHOCKI FRANK R JR
IPC: A61B17/06
Filed: 2004-12-03
Abstract: L'invention concerne une suture active permettant d'administrer des fluides thérapeutiques au tissu entourant une plaie, et éventuellement de fermer la plaie. L'invention permet d'administrer un volume efficace de solution véhiculant un médicament et de parvenir à un haut niveau de régulation de vitesse d'administration de fluides.
Patent EP-1687676-A2 (EP)
Title: Ensemble d'imagerie haute vitesse pour radiographie
Inventor: DICKERSON ROBERT EDWARD
IPC: G03C5/16
Filed: 2004-11-08
Abstract: Cette invention concerne un ensemble d'imagerie radiographique comprenant un film d'halogénure d'argent radiographique symétrique et présentant une vitesse système globale d'au moins 200 mais inférieure à 800 afin de produire des images présentant un meilleur contraste et une plus grande netteté ainsi qu'un voile réduit. L'ensemble d'imagerie comprend un film d'halogénure d'argent radiographique symétrique présentant une vitesse d'au moins 700 et comprenant deux émulsions d'halogénure d'argent appliquées de chaque côté du support et comprenant des grains d'halogénure d'argent tubulaires. Les émulsions les plus proches du support comprennent un agent de réduction de surimpression approprié. L'ensemble d'imagerie peut également comprendre une paire d'écrans renforçateurs fluorescents qui présentent une mesure de netteté de l'écran (SSM) supérieure à la courbe de référence A représentée dans la figure 4. Les écrans peuvent comprendre un support comportant un substrat réfléchissant comprenant une phase polyester continue et des microcavités contenant des particules organiques dispersées dans la phase polyester.
Patent EP-1555827-A2 (EP)
Inventor: TOMA TADAMASA
IPC: H04N7/24
Filed: 2005-01-14
Abstract: A multiplex scheme conversion apparatus (103) includes ( i )
a packet loss judgment unit 202 that judges the packet loss of a TS
packet, performs error processing in the case where a packet loss is
detected, and outputs the payload data on which error processing
has already been performed and ( ii ) a Box making unit 206 that
makes 'moov' including error information and 'mdat' based on
inputted AU data and the display time in a PES header.
Patent EP-1580831-A2 (EP)
Inventor: AMINO TOSHIKAZU
IPC: H01M4/86
Filed: 2005-03-21
Abstract: A solid-state polyelectrolyte type fuel cell is provided in a honeycomb
structure, including a plurality of honeycomb channels each having a polygonal
cross section and disposed in a row with adjacent ones being isolated from each
other with an isolation wall, is formed from a solid-state polyeletrolyte membrane,
each of some of the honeycomb channels has a fuel electrode disposed on the inner
wall thereof to provide a electrode channel while each of the other has an air
electrode disposed on the inner wall thereof to provide an air electrode, and
the fuel and air electrode channels are disposed to adjoin each other with the
isolation wall being laid between them, thereby to provided a fuel cell which is
compact, lightweight and inexpensive.
Patent EP-1589220-A2 (EP)
Inventor: KAYAMA RYOZO
IPC: F02D41/04
Filed: 2005-04-25
Abstract: A fuel injector (18) for an internal combustion engine (11) which has a
spray hole (25) designed geometrically to produce a spray of fuel so that
substantially 70% or more of an amount of the spray hits a
preselected area of a head (15) of an intake valve (150) of the engine when the
intake valve (150) is closed. The preselected area is one of a first and a
second area of the intake valve head (15) which are defined by a reference
boundary line extending through a base end of a stem (26) of the intake
valve (150). The preselected area is the first area closer to an intake
manifold (17), while the second area is closer to an exhaust valve (160). This
avoids rich misfire and reduces HC emissions from the engine (11)
regardless of the intake valve (150) is in a closed state or in an open state.
Patent EP-1619164-A2 (EP)
Inventor: LEE SANG-WOO
IPC: B81B3/00
Filed: 2005-07-19
Abstract: A vertical offset structure and a method for fabricating the same. The vertical offset structure includes a substrate; a fixed electrode fixing portion formed on the substrate; a fixed electrode moving portion formed at a position away from an upper portion of the substrate by a predetermined distance; a spring portion for connecting the fixed electrode fixing portion and the fixed electrode moving portion to each other so that the fixed electrode moving portion moves into a direction substantially perpendicular to a plate surface of the substrate; a movable electrode located away from the upper portion of the substrate by a predetermined distance to have a predetermined interval horizontal to the fixed electrode moving portion; and a cap wafer bonded to a predetermined area of one of the fixed electrode moving portion and the movable electrode.
Patent EP-1639992-A2 (EP)
Inventor: DANNECKER BEATE
IPC: A61K8/45
Filed: 1997-12-09
Abstract: Permanent waving agent for hair contains an N-branched chain alkyl-substituted mercaptoacetamide of formula (I) as keratin reducing agent. SH-CH2-CO-NHR1R2R3 (I) R1, R2, R3 = carboxy (COOH) or 1-6 carbon (C) alkyl or mono- or polyhydroxy alkyl or 1 or 2 of these groups = hydrogen (H); if R1 = R2 = H, R3 = COOH or branched 1-6 C alkyl or mono- or polyhydroxyalkyl; if none of R1, R2, R3 = COOH or branched 1-6 C alkyl or mono- or polyhydroxyalkyl, >= 2 of these groups = linear 1-6 C alkyl or mono- or poly-hydroxyalkyl; if one of R1, R2, R3 = COOH, the other two not = COOH. Also claimed is a permanent waving method using this agent.
Patent EP-1584685-A2 (EP)
Inventor: CABEZON SILVA TERESA
IPC: C07K14/315
Filed: 1999-02-02
Abstract: The present invention relates to novel proteins and to their production, from the
MAGE family. In particular, to a MAGE protein fused to an immunological fusion
partner, such as Lipoprotein D. Such antigens maybe formulated to provide vaccines
for the treatment of a range of tumours. Novel methods for purifying MAGE proteins
are also provided.
Patent EP-1625891-A2 (EP)
Inventor: INSAUSTI-ECIOLAZA SATURNINO
IPC: B05B1/04
Filed: 2005-08-10
Abstract: A process for the airless spray-coating of a surface with a viscous aqueous non-Newtonian architectural coating composition wherein the composition contains a preferably associative thickener and is subjected to a pressure of from 2.5 to 5 bar generated preferably by hand-operated compressor and then sprayed from a preferably slot-shaped outlet orifice (52) in a nozzle (50) to produce an outflow (31) of composition having boundaries (35) which diverge at least until it has formed a front of at least 30mm in width. The composition preferably has a Brookfield viscosity of at least 0.5 pa.sec and a solids content of 7 wt %. 
     Also apparatus for performing the process comprising a container containing the coating composition together with a nozzle having an outlet orifice, a hand-operated compressor and a pressure release valve actuatable in the pressure range 2.5 to 5 bar and preferably an auxiliary orifice upstream of the outlet orifice. 
     The process and apparatus enable the viscous compositions to be applied quickly using low pressures easily generated by a hand compressor.
Patent EP-1589791-A2 (EP)
Inventor: KAMMERL FRANZ
IPC: H05B37/00
Filed: 2005-04-15
Abstract: The aim is to increase the application of high impedance bypassed installation switches. The invention features a bypass device to bypass an electrical load, which is to be switched with an installation switch. The bypass device is a switching power supply (N2, N3, T1). By means of the switching power supply, an electrical impedance (L1, R2) can be connected in parallel to the load, which is to be switched. The bypass can be carried out at very low impedance during low current load (switch and load OFF), in order to supply consumer items with current. With full mains voltage (switch and load ON) the bypass can be switched to high impedance to keep energy consumption low.
Patent EP-1615117-A2 (EP)
Inventor: MACAULEY JAMES D
IPC: A63F13/06
Filed: 2005-04-26
Abstract: A system architecture within a multimedia console having a host application that provides information to a user related to a configuration of a controller of a multimedia application with which user is currently interacting A system application residing in the memory and running concurrently with a multimedia application receives a request to display the active controller configuration and displays a graphical representation of the active configuration. The configuration may be stored in a user profile and retrieved or applied to all similar types of applications.
Patent EP-1602969-A2 (EP)
Inventor: HOSHUYAMA HIDEO
IPC: G03B7/16
Filed: 2005-05-23
Abstract: An illumination device includes a light source
constituted with an LED which is a trichromatic
(three-wavelength) light source achieving maximum light
emission wavelengths in separate wavelength ranges
corresponding to the three primary colors of light, blue, green
and red. As the shutter is released at an electronic camera
set in a portrait photographing mode, the electronic camera
transmits a light emission command for the illumination device
to illuminate the main subject with illuminating light emitted
from the LED. The LED assumes a structure that allows it to
emit light at maximum light emission wavelengths matching
maximum transmission wavelengths achieved through the
spectral transmission characteristics of a color filter
disposed at an image-capturing element.
Patent EP-1622386-A2 (EP)
Inventor: VIRDI GURPRATAP
IPC: H04N7/173
Filed: 2005-07-29
Abstract: Strategies are described for transmitting control information from a host module to a client module. The host module transmits the control information in-band along with a stream of media content information packets. The control information can be used to govern the operation of the client module. In one case, the control information alerts the client module to a discontinuity in streams, which may be the result of the user changing channels via the host or client module, etc., issuing a seek instruction, and so forth. Transmitting the control information in in-band fashion is advantageous because it reduces the need for complex linking between the control information and the associated content information.
Patent EP-1586744-A2 (EP)
Inventor: CORMIER NATHAN GERARD
IPC: F01D17/16
Filed: 2005-04-14
Abstract: A variable vane assembly (44) for a gas turbine engine includes a casing (50).
The assembly comprises a variable vane (52) which includes a radially inner
spindle (70) and a radially outer spindle (54). The radially inner and outer
spindles are configured to rotatably couple the vane within the gas turbine
engine. At least one of the radially inner and radially outer spindles comprises
at least one groove (80) defined therein, at least one groove comprises at
least one machined face (86), and a retainer for engaging the groove at least
one machined face to securely couple the variable vane within the gas turbine
engine, the retainer is configured to facilitate reducing wear of the variable
vane.
Patent EP-1690771-A2 (EP)
Inventor: KONISHI KENTA
IPC: B61F5/10
Filed: 2005-08-25
Abstract: The invention provides an overload detector with a simplified system configuration to be applied to an articulated railway car having at least a common bogie connecting two adjacent car bodies. A connecting two axle bogie (52) having front and rear wheels (52C,52D) is disposed to extend between a first car (C 1 ) and a second car (C 2 ). The first and second cars (C 1 ,C 2 ) are supported via second air springs (52A,52B) on the connecting bogie (52). The other end of the first car (C 1 ) is supported via first air springs (51A,51B) on a two axle bogie(51) having front and rear wheels (51C,51D). The other end of the second car (C 2 ) is supported via third air springs (53A,53B) on a two axle bogie (53) having front and rear wheels (53C,53D). 
Pneumoelectric converters (41,42) are disposed along paths of pneumatic pipings (21,22), and the inner pressure (P AS1 ) of the first air springs (51A,51B) is converted into an inner pressure signal (AS1), and the inner pressure (P AS2 ) of the second air springs (52A,52B) is converted into an inner pressure signal (AS2). The inner pressure signals (AS1,AS2) output from the pneumoelectric converters (41,42) are input to a computing processor (3). Overload is determined based on signals (AS1,S2).
Patent EP-1561777-A2 (EP)
Inventor: WU JINHUANG
IPC: C08G101/00
Filed: 2005-01-04
Abstract: A method for improving pentane-blown foam is provided, which method
comprises incorporating into the foam composition
trans-1,2-dichlorethylene in an amount effective to suppress the smoke
generation of the blown foam.
Patent EP-1720715-A2 (EP)
Inventor: CRACKNELL JOHN
IPC: B42D9/00
Filed: 2005-01-28
Abstract: Binding apparatus and a related process are particularly suited for binding digitally-printed sheets into booklets. The apparatus is adapted to fold individual sheets and then to apply adhesive to the fold line before gathering the sheets in a collator ready for binding. The collator includes either a rotatable or retractable finger that is moveable to temporarily inhibit registration of a first sheet of a new stack on a stacking area, as a previous stack is transported away.
Patent EP-1745398-A2 (EP)
Inventor: PERRY JEFFREY S
IPC: G06F19/00
Filed: 2005-03-30
Abstract: Un appareil d'interaction pour patient (10) comprend un serveur médical (13) générant une enquête de réflexion sur des sujets d'intérêt, (notamment des signes vitaux anormaux ou indésirables) dans des données objectives ou subjectives reportées à partir d'un dispositif interface patient (11). L'enquête réagit aux résultats objectifs dans le but de sonder la pathologie actuelle d'un patient. L'enquête sur le patient veut connaître spécifiquement la raison pour laquelle le poids du patient, la pression sanguine, ou la fréquence du pouls, pour ne citer que quelques exemples, peut être supérieur(e) que prévu. D'autres procédés de détermination des conditions d'apparition et d'élimination de signes vitaux rapportés de manière erronée. Les données objectives ou subjectives du patient comprennent les données suivantes: la pression sanguine, la fréquence du pouls, la température, le poids, l'électrocardiogramme, l'électroencéphalogramme, l'onde cérébrale, le modèle respiratoire, les mesures biochimiques, le glucose sérique, les gaz sanguins, les données physiologiques, les données non physiologiques, les mesures d'exercice ou d'activité, la présence ou l'absence de mesures, ou toute fonction de données objectives ou subjectives que l'on peut mesurer ou déduire en observant le patient.
Patent EP-1730060-A2 (EP)
Inventor: RAPKIN ALAN EARL
IPC: B65H1/04
Filed: 2005-03-29
Abstract: Selon un aspect, la présente invention concerne un chargeur feuille à feuille ajustable destiné à être utilisé dans un appareil d'alimentation en feuilles à partir du haut d'une pile d'alimentation en feuilles. La pile d'alimentation en feuilles possède un centre et des bords marginaux, chacun ayant une partie supérieure. Ledit chargeur feuille à feuille ajustable comprend un support de pile d'alimentation en feuilles, un ensemble tête d'alimentation en feuilles et un dispositif de détection de gondolage qui détecte la position des bords de la pile par rapport à la position de la partie supérieure centrale de la pile et fournit un retour d'information, un dispositif d'ajustement et un afficheur de retour d'information qui affiche le retour d'information du dispositif de détection de gondolage. Le dispositif d'ajustement ajuste la position de la partie supérieure centrale de la pile par rapport à la position de la partie supérieure des bords marginaux de la pile sur la base du retour d'information fourni par le dispositif de détection de gondolage.
Patent EP-1723127-A2 (EP)
Inventor: MILLER DUANE D
IPC: C07D277/04
Filed: 2005-02-11
Abstract: La présente invention a trait à des analogues inhibiteurs de la prolifération cellulaire. L'invention a également trait à des procédés de fabrication des analogues. Les analogues peuvent être utilisés pour le traitement de conditions cancéreuses telles que le cancer de la prostate, du sein et de l'ovaire.
Patent EP-1763768-A2 (EP)
Title: Method and device for controlling a bus system, and corresponding bus system
Inventor: HARTWICH FLORIAN
IPC: G06F13/42
Filed: 2005-06-06
Abstract: The invention relates to a method for controlling a bus system with at least two subscribers. According to said method, a first subscriber repeatedly transmits a reference message over the bus system during at least one pre-determinable interval, said reference message being triggered by temporal trigger information when the time information reaches a time mark associated with the trigger information. The inventive method is characterised in that the time mark is modified at least once in such a way that when the modified time mark is reached, the trigger information is temporally shifted by the time information.
Patent EP-1747005-A2 (EP)
Inventor: SANTI DANIEL V
IPC: C07D225/06
Filed: 2005-05-19
Abstract: La présente invention se rapporte à des composés de geldanamycine, qui sont représentés par la formule (I), dans laquelle Q1, L, L1, R5, R6 et R11 sont tels que définis dans le descriptif de l'invention. Les composés selon l'invention sont utiles pour traiter une maladie ou un trouble atténués par l'inhibition de la fonction de la protéine de choc thermique 90.